Phase 2
Completed N=81
A Study to Evaluate the Efficacy and Safety of CT-P27 in an Influenza Challenge Model
Source: ClinicalTrials.gov NCT02071914 ↗Enrolled (actual)
81
Serious AEs
0.0%
Results posted
Mar 2020
Primary outcomePrimary: Viral Load AUC (Day 1 to Day 9) by Nasopharyngeal Swab Quantitative PCR — 6.474; 6.974; 11.639 Days*Eq log10 TCID50/mL
Summary
This study is to evaluate the efficacy of CT-P27 measured by quantitative PCR viral load from nasopharyngeal mucosa, compared to placebo.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Viral Load AUC (Day 1 to Day 9) by Nasopharyngeal Swab Quantitative PCR |
6.474; 6.974; 11.639 | — |
Eligibility Criteria
Inclusion Criteria
- Healthy Male & Female volunteers
Exclusion Criteria
- Current clinically significant disease
- Pregnant or nursing mother
- Abnormal pulmonary function, nose or nasopharynx
Data sourced from ClinicalTrials.gov (NCT02071914). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.